<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Approximate dose conversions for commonly used opioids (refer to important note below)</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Approximate dose conversions for commonly used opioids (refer to important note below)</h1>
<div class="graphic"><div class="figure"><div class="ttl">Approximate dose conversions for commonly used opioids (refer to important note below)</div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="14%"></colgroup><colgroup span="2" width="22%"></colgroup> <tbody> <tr> <td class="subtitle1_left" colspan="6">Approximate dose conversions for commonly used opioids (refer to important notes below)</td> </tr> <tr class="divider_top"> <td class="subtitle2" colspan="2">Morphine</td> <td class="subtitle2" colspan="2">Hydromorphone (Dilaudid)</td> <td class="subtitle2">Oxycodone</td> <td class="subtitle2">Fentanyl transdermal*</td> </tr> <tr> <td class="subtitle3">IV (mg/day)</td> <td class="subtitle3">Oral (mg/day)</td> <td class="subtitle3">IV (mg/day)</td> <td class="subtitle3">Oral (mg/day)</td> <td class="subtitle3">Oral (mg/day)</td> <td class="subtitle3">Patch (mcg/hour)</td> </tr> <tr class="centered"> <td>5</td> <td>15</td> <td>0.75</td> <td>3.5</td> <td>10</td> <td>NA</td> </tr> <tr class="centered"> <td>8.5</td> <td>25</td> <td>1.25</td> <td>6.5</td> <td>15</td> <td>12</td> </tr> <tr class="centered"> <td>10</td> <td>30</td> <td>1.5</td> <td>7.5</td> <td>20</td> <td>12</td> </tr> <tr class="centered"> <td>17</td> <td>50</td> <td>2.5</td> <td>12.5</td> <td>30</td> <td>25</td> </tr> <tr class="centered"> <td>33</td> <td>100</td> <td>5</td> <td>25</td> <td>65</td> <td>50</td> </tr> <tr class="centered"> <td>50</td> <td>150</td> <td>7.5</td> <td>37.5</td> <td>100</td> <td>75</td> </tr> <tr class="centered"> <td>67</td> <td>200</td> <td>10</td> <td>50</td> <td>130</td> <td>100</td> </tr> <tr class="centered"> <td>83</td> <td>250</td> <td>12.5</td> <td>62.5</td> <td>165</td> <td>125</td> </tr> <tr class="centered"> <td>100</td> <td>300</td> <td>15</td> <td>75</td> <td>200</td> <td>150</td> </tr> <tr class="centered"> <td>117</td> <td>350</td> <td>17.5</td> <td>87.5</td> <td>230</td> <td>175</td> </tr> <tr class="centered"> <td>133</td> <td>400</td> <td>20</td> <td>100</td> <td>265</td> <td>200</td> </tr> <tr class="centered"> <td>150</td> <td>450</td> <td>22.5</td> <td>112.5</td> <td>300</td> <td>225</td> </tr> <tr class="centered"> <td>167</td> <td>500</td> <td>25</td> <td>125</td> <td>330</td> <td>250</td> </tr> <tr class="centered"> <td>183</td> <td>550</td> <td>27.5</td> <td>137.5</td> <td>360</td> <td>275</td> </tr> <tr class="centered divider_bottom"> <td>200</td> <td>600</td> <td>30</td> <td>150</td> <td>400</td> <td>300</td> </tr> <tr class="divider_top"> <td class="subtitle1_left" colspan="6">Conversion ratios to determine daily total ORAL morphine milligram equivalent (MME)</td> </tr> <tr class="divider_top"> <td class="subtitle2_left" colspan="2">Drug</td> <td class="subtitle2_left" colspan="2">Approximate equivalent oral dose</td> <td class="subtitle2_left">Approximate equivalent IV or subcutaneous dose</td> <td class="subtitle2_left">Conversion ratio to determine daily total ORAL morphine milligram equivalent (MME)</td> </tr> <tr class="divider_top"> <td colspan="2">Morphine</td> <td colspan="2">30 mg</td> <td>10 mg</td> <td> <ul> <li>Parenteral morphine to oral morphine: 1:3</li> </ul> </td> </tr> <tr> <td colspan="2">Fentanyl</td> <td colspan="2">Not available</td> <td>0.1 mg (100 mcg)</td> <td> <ul> <li>Parenteral fentanyl to oral morphine: 1:300</li> </ul> </td> </tr> <tr> <td colspan="2">Hydrocodone</td> <td colspan="2">30 mg</td> <td>Not available</td> <td> <ul> <li>Oral hydrocodone to oral morphine: 1:1<sup>¶</sup></li> </ul> </td> </tr> <tr> <td colspan="2">Hydromorphone</td> <td colspan="2">7.5 mg</td> <td>1.5 mg</td> <td> <ul> <li>Oral hydromorphone to oral morphine: 1:4</li> <li>Parenteral hydromorphone to oral morphine: 1:20</li> </ul> </td> </tr> <tr> <td colspan="2">Oxycodone</td> <td colspan="2">20 mg</td> <td>Not available</td> <td> <ul> <li>Oral oxycodone to oral morphine: 1:1.5</li> </ul> </td> </tr> <tr> <td colspan="2">Oxymorphone</td> <td colspan="2">10 mg</td> <td>1 mg</td> <td> <ul> <li>Oral oxymorphone to oral morphine: 1:3</li> <li>Parenteral oxymorphone to oral morphine: 1:30</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_lgnd"><strong>Important notes:</strong>
<ul>
<li>The doses included here provide a starting point for the purpose of comparing and switching different opioids during maintenance therapy; these are <strong>not</strong> recommended doses for the initiation of opioid therapy.</li>
<li>Equianalgesic conversions serve only as a general guide to estimate opioid dose equivalents. When switching to a <strong>new</strong> opioid, the initial daily dose for the new opioid determined by using the conversions in the first part of this table should be <strong>further reduced by 25 to 50%</strong> to adjust for lack of complete mu receptor cross-tolerance (except when switching to methadone, which requires a 75 to &gt;90% reduction; refer to UpToDate topics on cancer pain management with opioids, optimizing analgesia). In contrast, when switching between intravenous and oral administration of the <strong>same</strong> opioid, an empiric reduction of the equianalgesic dose estimate shown above is generally not necessary.</li>
<li>The calculated starting dose of the new opioid or new route of administration will require monitoring and further titration after making the conversion. For a review of multiple factors that must be considered for safely individualizing conversion of opioid analgesia in patients with cancer, refer to UpToDate topics on cancer pain management with opioids, optimizing analgesia.</li>
<li>The approximate equivalences have been rounded. Further rounding may be necessary for available tablet strengths.</li>
<li>The second part of this table provides conversion factors to assess the total daily <strong>oral</strong> morphine milligram equivalent (MME) dose. Total daily oral MME dose &gt;50 mg is one factor among several that can help identify patients who may be at higher risk for overdose and may benefit from closer monitoring and coprescription of naloxone. A high daily MME dose may also be useful for identifying tolerance, and can suggest that a patient may benefit from opioid rotation. For further information refer to UpToDate content on chronic pain management.</li>
</ul></div><div class="graphic_footnotes">IV: intravenous; mcg: microgram.<br/>* Suggested doses for conversion to transdermal fentanyl from other opioids are less conservative than recommendations in the United States product labeling. The recommendations in this table are based on guidance available at experienced centers.<br/>¶ Wide interpatient variability in response.</div><div class="graphic_reference">Courtesy of Kathleen Broglio, DNP, MN, ANP-BC, ACHPN and Russell K Portenoy, MD.<br/>
Additional data from:
<ol>
<li>National Comprehensive Cancer Network. Adult Cancer Pain, Version 2.2021.</li>
<li>Lexicomp Online. Copyright © 1978-2024 Lexicomp, Inc. All Rights Reserved.</li>
</ol></div><div id="graphicVersion">Graphic 111216 Version 12.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
